U.S. markets open in 5 hours 55 minutes

HSBC Global Strategy Dynamic Portfolio Accumulation C (0P0000WN7V.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
270.61+0.28 (+0.10%)
As of 08:00PM GMT. Market open.
Full screen
Previous Close270.33
YTD Return-7.26%
Expense Ratio (net)0.00%
Last Cap Gain0.00
Morningstar Rating★★★★★
Morningstar Risk RatingAbove Average
Sustainability Rating
Net Assets806.79M
Beta (5Y Monthly)1.07
5y Average ReturnN/A
Holdings TurnoverN/A
Last Dividend0.02
Average for CategoryN/A
Inception DateNov 01, 2012
  • PR Newswire

    ArcBest Releases Annual Environmental, Social and Governance Report

    ArcBest® (Nasdaq: ARCB), a leader in supply chain logistics, today released its third annual Environmental, Social and Governance (ESG) report, highlighting the company's significant progress and ongoing efforts in building a safer, more sustainable and more inclusive company and world. The report features ArcBest's roadmap for achieving and surpassing important diversity, equity and inclusion (DEI) milestones, as well as new disclosures on climate risk management inclusive of Scope 1 and Scope

  • PR Newswire

    ABF Freight to Host Columbus, Ohio-Area Hiring Event

    ArcBest® (Nasdaq: ARCB), a leader in supply chain logistics, announced today that its less-than-truckload carrier, ABF Freight®, will host a hiring event in Columbus, Ohio, on June 7, for full-time city drivers.

  • Business Wire

    Antibe Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference

    TORONTO, April 25, 2022--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, today announced its participation in the 2022 Bloom Burton & Co. Healthcare Investor Conference being held in person on May 2-3, 2022. Dan Legault, Antibe’s CEO, and Dr. Joseph Stauffer, Chief Medical Officer, will deliver the Company’s live presentation: